Tech Company Financing Transactions
Idev Technologies Funding Round
Idev Technologies closed a $46 million Series D funding round on 10/7/2010. Investors included Bay City Capital, Heron Capital and Piper Jaffray Ventures.
Transaction Overview
Company Name
Announced On
10/7/2010
Transaction Type
Venture Equity
Amount
$46,000,000
Round
Series D
Proceeds Purpose
The proceeds from the financing will be used to fund SUPERB, the ongoing, multi-center IDE superficial femoral artery clinical trial for the company's self-expanding SUPERA stent, new clinical trials in support of other peripheral artery indications, the development of new interventional products, and sales and marketing initiatives to support continued revenue growth.
Company Information
Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
253 Medical Center Blvd.
Webster, TX 77598
USA
Webster, TX 77598
USA
Phone
Website
Email Address
Overview
IDev Technologies, Inc. is an organization focused on innovation, inspiration, and next generation medical device products designed for endovascular interventional use.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Christopher Owens
Chief Financial Officer
William Burke
Chief Medical Officer
Dennis Donohoe
VP - Finance
John Dame
VP - Operations
Charles Tribie
VP - Sales
Eric Schlote
Browse more venture capital transactions:
Prev: 10/7/2010: Phoenix Biotechnology venture capital transaction
Next: 10/7/2010: Sun Catalytix venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs